{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:36:01Z","timestamp":1767915361965,"version":"3.49.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.588724","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T12:23:22Z","timestamp":1601468602000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?\u2014Lessons Learned From Cancer"],"prefix":"10.3389","volume":"11","author":[{"given":"Antonio","family":"Barbieri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmal","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Palma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Maurea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Desiderio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Botti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses-drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat Rev Drug Discovery"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2013.05.010","article-title":"The emerging novel Middle East respiratory syndrome coronavirus: The \u201cknowns\u201d and \u201cunknowns","volume":"112","author":"Chan","year":"2013","journal-title":"J Formos Med Assoc"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00023-07","article-title":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection","volume":"20","author":"Cheng","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/CMR.00102-14","article-title":"Middle East Respiratory syndrome coronavirus: Another zoonotic betacoronavirus causing SARS-like disease","volume":"28","author":"Chan","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"B5","unstructured":""},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050828","article-title":"Multiple organ infection and the pathogenesis of SARS","volume":"202","author":"Gu","year":"2005","journal-title":"J Exp Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/path.1560","article-title":"Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways","volume":"203","author":"Ding","year":"2004","journal-title":"J Pathol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taaa041","article-title":"Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19","volume":"27","author":"Diaz","year":"2020","journal-title":"J Travel Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1002\/jmv.25766","article-title":"Coronavirus Disease 2019 (COVID-19): What we know","volume":"2019","author":"He","year":"2020","journal-title":"J Med Virol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/JLB.3COVR0520-272R","article-title":"Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts","volume":"108","author":"Wang","year":"2020","journal-title":"J Leukoc Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.03.005","article-title":"TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib","volume":"53","author":"Wu","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088716","article-title":"Distinct immune response in two MERS-CoV-infected patients: Can we go from bench to bedside","volume":"9","author":"Faure","year":"2014","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00165-13","article-title":"Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus","volume":"4","author":"Josset","year":"2013","journal-title":"MBio"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2011.165","article-title":"IL-17 response mediates acute lung injury induced by the 2009 Pandemic Influenza A (H1N1) Virus","volume":"22","author":"Li","year":"2012","journal-title":"Cell Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jaci.2005.11.012","article-title":"Molecular mechanisms of \u03b22-adrenergic receptor function, response, and regulation","volume":"117","author":"Johnson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1159\/000339271","article-title":"Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application","volume":"122","author":"Wachter","year":"2012","journal-title":"Cardiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1164\/arrd.1985.132.3.541","article-title":"Autoradiographic visualization of beta-adrenoceptor subtypes in human lung","volume":"132","author":"Carstairs","year":"1985","journal-title":"Am Rev Respir Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01313","article-title":"Bidirectional role of \u03b22-adrenergic receptor in autoimmune diseases","volume":"9","author":"Wu","year":"2018","journal-title":"Front Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2011.05.013","article-title":"\u03b22-Adrenergic agonists bias TLR-2 and NOD2 activated dendritic cells towards inducing an IL-17 immune response","volume":"55","author":"Manni","year":"2011","journal-title":"Cytokine"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1159\/000360579","article-title":"Regulation of Differentiation and Function of Helper T Cells by Lymphocyte-Derived Catecholamines via \u03b11 - and \u03b22 -Adrenoceptors","volume":"22","author":"Huang","year":"2015","journal-title":"Neuroimmunomodulation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000343099","article-title":"Lymphocyte-derived catecholamines induce a shift of Th1\/Th2 balance toward Th2 polarization","volume":"20","author":"Huang","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/0889-1591(92)90016-H","article-title":"Stress-induced alterations in interferon production and class II histocompatibility antigen expression","volume":"6","author":"Sonnenfeld","year":"1992","journal-title":"Brain Behav Immun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.chom.2012.03.002","article-title":"Nondegradative role of Atg5-Atg12\/Atg16L1 autophagy protein complex in antiviral activity of interferon gamma","volume":"11","author":"Hwang","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00231-09","article-title":"Type I and Type II Interferons Inhibit the Translation of Murine Norovirus Proteins","volume":"83","author":"Changotra","year":"2009","journal-title":"J Virol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.158.3.670","article-title":"Identification of interferon-\u03b3, as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity","volume":"158","author":"Nathan","year":"1983","journal-title":"J Exp Med"},{"key":"B28","article-title":"Enhancement of mouse natural killer cell activity by type II interferon","author":"Senik","year":"","journal-title":"Ann Immunol (Paris)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/309801a0","article-title":"Gamma-interferon is one of several direct B cell-maturing lymphokines","volume":"309","author":"Sidman","year":"1984","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.7.3571","article-title":"Distinct Requirements for IFNs and STAT1 in NK Cell Function","volume":"165","author":"Lee","year":"2000","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2017.09.052","article-title":"ILC1 Confer Early Host Protection at Initial Sites of Viral Infection","volume":"171","author":"Weizman","year":"2017","journal-title":"Cell"},{"key":"B32","first-page":"70","article-title":"Long acting propranolol and HSP-70 rich tumor lysate reduce tumor growth and enhance immune response against fibrosarcoma in Balb\/c mice","volume":"10","author":"Khalili","year":"2013","journal-title":"Iran J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s13054-015-0913-x","article-title":"Propranolol attenuates hemorrhage and accelerates wound healing in severely burned adults","volume":"19","author":"Ali","year":"2015","journal-title":"Crit Care"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/01.wad.0000155067.16313.5e","article-title":"Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease: A placebo-controlled study","volume":"19","author":"Peskind","year":"2005","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/00005053-198605000-00005","article-title":"Propranolol treatment of assaultive patients with organic brain disease: A double-blind crossover, placebo-controlled study","volume":"174","author":"Greendyke","year":"1986","journal-title":"J Nerv Ment Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bbi.2018.05.014","article-title":"Perioperative inhibition of \u03b2-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome","volume":"73","author":"Haldar","year":"2018","journal-title":"Brain Behav Immun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501677","article-title":"Propranolol Attenuates Surgical Stress\u2013Induced Elevation of the Regulatory T Cell Response in Patients Undergoing Radical Mastectomy","volume":"196","author":"Zhou","year":"2016","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0152","article-title":"Perioperative COX-2 and \u03b2-Adrenergic Blockade Improves Metastatic Biomarkers in Breast Cancer Patients in a Phase-II Randomized Trial","volume":"23","author":"Shaashua","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12404","article-title":"Effect of \u03b2-blockers on platelet aggregation: A systematic review and meta-analysis","volume":"78","author":"Bonten","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0b013e318161ea63","article-title":"The effects of aspirin and nonselective beta blockade on the acute prothrombotic response to psychosocial stress in apparently healthy subjects","volume":"51","author":"von K\u00e4nel","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2004.00851.x","article-title":"Beta-receptor blockade decreases elevated plasma levels of factor VIII: C in patients with deep vein thrombosis","volume":"2","author":"Hoppener","year":"2004","journal-title":"J Thromb Haemost"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2011.01375.x","article-title":"Role of endothelial nitric oxide synthase (eNOS) in chronic stress-promoted tumour growth","volume":"16","author":"Barbieri","year":"2012","journal-title":"J Cell Mol Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2015.3038","article-title":"The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo","volume":"47","author":"Barbieri","year":"2015","journal-title":"Int J Oncol"},{"key":"B44","article-title":"Therapeutic Approaches for COVID-19 Based on the Dynamics of Interferon-mediated Immune Responses","volume-title":"Preprints","author":"Shahabi nezhad","year":"2020"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe"},{"key":"B46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12967-020-02333-9","article-title":"Anti-IL6R role in treatment of COVID-19-related ARDS","volume":"18","author":"Buonaguro","year":"2020","journal-title":"J Transl Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780230220","article-title":"Propranolol and the treatment of rheumatoid arthritis","volume":"23","author":"Kaplan","year":"1980","journal-title":"Arthritis Rheum"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa078","article-title":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2","volume":"116","author":"Chen","year":"2020","journal-title":"Cardiovasc Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1348-y","article-title":"\u03b2-Adrenergic receptors (\u03b2-AR) regulate VEGF and IL-6 production by divergent pathways in high \u03b2-AR-expressing breast cancer cell lines","volume":"130","author":"Madden","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2013.08.005","article-title":"Norepinephrine and adenosine-5\u2019-triphosphate synergize in inducing IL-6 production by human dermal microvascular endothelial cells","volume":"64","author":"Stohl","year":"2013","journal-title":"Cytokine"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2008.10.005","article-title":"Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: Implications for stress-related enhancement of tumor progression","volume":"23","author":"Yang","year":"2009","journal-title":"Brain Behav Immun"},{"key":"B53","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1167\/iovs.16-20204","article-title":"\u03b22\u2013adrenergic receptor antagonism attenuates CNV through inhibition of VEGF and IL-6 expression","volume":"58","author":"Lavine","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2019.01.004","article-title":"\u03b2-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease \u2013 A Danish Nationwide Study of 1\u00b73 Million Individuals","volume":"7","author":"Nielsen","year":"2019","journal-title":"EClinicalMedicine"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S46592","article-title":"Beta-blockers: Friend or foe in asthma","volume":"6","author":"Arboe","year":"2013","journal-title":"Int J Gen Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.588724\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T12:23:25Z","timestamp":1601468605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.588724\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2020.588724"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.588724","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]},"article-number":"588724"}}